 |
 |
Inside
the cells of all living
organisms are elaborate
communication networks that
control the cellular
response to external
stimuli. Protein 'teams’
work in concert to execute
pathway instructions such
as, gene regulation, cell
growth, movement, and
hormone release. When these
communication networks fail
to execute an instruction,
or when signaling becomes
deregulated, diseases
including cancer, diabetes,
and obesity, result.
At P.A.
Technologies, our in vitro
assembly technology
reassembles ‘teams’ of
signaling proteins, allowing
drug developers and
researchers to conduct
rapid, accurate assessments
of molecules that target
these pathways.
|
| |
|
|
|
|
At P. A.
Technologies we have created a
novel, easy to use technology for
the study of today’s important drug
targets: TDA 2.0. Our
templating technology places
proteins back in their native
membrane environment without the
complexities of cell based assays or
the difficulty or reconstituting
membrane proteins. These proteins
exhibit increased biological
function and resorted molecular
recognition. Stop looking in the
rear view mirror –
contact us
today!
|
|
 |
|
 |
Blue Sky
Biotech, Inc. and
Protein
Attachment Technologies, LLC
have entered into a global,
exclusive license agreement
covering PA Tech’s
proprietary Template
Directed Assembly (TDA 2.0™)
technology for use in
High-Throughput Screening (HTS)
of drug candidates against
membrane-associated protein
targets. The emerging
product line is a
combination of Blue Sky’s
premium kinases and our
templating technology – we
call this new screening
platform SmartScreenTM.
We encourage all of our
customers to visit our new
home at Blue Sky BioProducts
via these icons!
Thank you for your business
and we look forward our
continued assistance in your
discovery efforts!
 |
|
|
 |
|
